GlassScriptPhysician profile
Brian L Mealey
NPI 1609958693
$28,075.81
in general payments reported to CMS, 2019-2025
7 companies · $5,520 in 2025
The $5,520 reported for 2025 was more than what 96% of Periodontics providers received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $5,131 · 2021: $410 · 2022: $8,979 · 2023: $1,687 · 2024: $6,000 · 2025: $5,520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,525 · Honoraria: $3,800 · Travel and Lodging: $1,220 · Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,525.00 |
| Honoraria | $3,800.00 |
| Travel and Lodging | $1,220.23 |
| Food and Beverage | $661.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osteogenics Biomedical INC. | $13,845.95 | 2020-2022 | |
| Zimvie INC. | $8,437.83 | 2022-2025 | |
| Geistlich Pharma, North America, INC. | $4,761.31 | 2019-2025 | Bio-Materials, Bio-Gide, Geistlich Bio-Gide |
| Straumann USA LLC | $748.93 | 2019-2024 | |
| Nobel Biocare USA | $145.23 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $120.50 | 2019-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $16.06 | 2023 | Arestin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mealey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.